246 related articles for article (PubMed ID: 32322977)
1. [Autologous hematopoietic stem cell transplantation for systemic sclerosis : Position statement of the stem cell therapy working party of the German Society of Rheumatology].
Alexander T; Henes J; Distler JHW; Schmalzing M; Blank N; Kötter I; Hiepe F
Z Rheumatol; 2020 Jun; 79(5):429-436. PubMed ID: 32322977
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M
Front Immunol; 2021; 12():817893. PubMed ID: 35111167
[TBL] [Abstract][Full Text] [Related]
3. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.
Puyade M; Maltez N; Lansiaux P; Pugnet G; Roblot P; Colmegna I; Hudson M; Farge D
Rheumatology (Oxford); 2020 Apr; 59(4):779-789. PubMed ID: 31504944
[TBL] [Abstract][Full Text] [Related]
5. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis.
Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A
Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527
[TBL] [Abstract][Full Text] [Related]
6. Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.
Sullivan KM; Majhail NS; Bredeson C; Carpenter PA; Chatterjee S; Crofford LJ; Georges GE; Nash RA; Pasquini MC; Sarantopoulos S; Storek J; Savani B; St Clair EW
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1961-1964. PubMed ID: 29953945
[TBL] [Abstract][Full Text] [Related]
7. Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners.
Farge D; Burt RK; Oliveira MC; Mousseaux E; Rovira M; Marjanovic Z; de Vries-Bouwstra J; Del Papa N; Saccardi R; Shah SJ; Lee DC; Denton C; Alexander T; Kiely DG; Snowden JA
Bone Marrow Transplant; 2017 Nov; 52(11):1495-1503. PubMed ID: 28530671
[TBL] [Abstract][Full Text] [Related]
8. Autologous Haematopoietic Stem Cell Transplantation and Systemic Sclerosis: Focus on Interstitial Lung Disease.
Bagnato G; Versace AG; La Rosa D; De Gaetano A; Imbalzano E; Chiappalone M; Ioppolo C; Roberts WN; Bitto A; Irrera N; Allegra A; Pioggia G; Gangemi S
Cells; 2022 Mar; 11(5):. PubMed ID: 35269465
[TBL] [Abstract][Full Text] [Related]
9. Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.
Dulko AJ; Butrimiene I; Cypiene A; Peceliunas V; Petroska D; Stankeviciene E; Rugiene R
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541223
[TBL] [Abstract][Full Text] [Related]
10. Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation.
Broens B; van der Laken CJ; Zwezerijnen GJC; Nossent EJ; Meijboom LJ; Spierings J; de Vries-Bouwstra JK; van Laar JM; Voskuyl AE
Front Immunol; 2022; 13():923869. PubMed ID: 35865521
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplantation in scleroderma.
Farge D; Ait Abdallah N; Marjanovic Z; Del Papa N
Presse Med; 2021 Apr; 50(1):104065. PubMed ID: 33548374
[TBL] [Abstract][Full Text] [Related]
12. The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.
Servaas NH; Spierings J; Pandit A; van Laar JM
Clin Exp Immunol; 2020 Jul; 201(1):34-39. PubMed ID: 31990046
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary mucormycosis following autologous hematopoietic stem cell transplantation for rapidly progressive diffuse cutaneous systemic sclerosis: A case report.
Boumaza X; Lelièvre L; Guenounou S; Borel C; Huynh A; Beziat G; Delavigne K; Guinault D; Garric M; Piel-Julian M; Paricaud K; Moulis G; Astudillo L; Sailler L; Farge D; Pugnet G
Medicine (Baltimore); 2020 Jul; 99(31):e21431. PubMed ID: 32756151
[TBL] [Abstract][Full Text] [Related]
14. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome.
Pecher AC; Klein R; Koetter I; Wagner M; Vogel W; Wirths S; Lengerke C; Henes JC
Arthritis Res Ther; 2024 Mar; 26(1):75. PubMed ID: 38509633
[TBL] [Abstract][Full Text] [Related]
15. Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
Boukouaci W; Lansiaux P; Lambert NC; Picard C; Clave E; Cras A; Marjanovic Z; Farge D; Tamouza R
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806227
[TBL] [Abstract][Full Text] [Related]
16. Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern.
Gernert M; Tony HP; Schwaneck EC; Gadeholt O; Schmalzing M
Arthritis Res Ther; 2019 Apr; 21(1):106. PubMed ID: 31036055
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
[TBL] [Abstract][Full Text] [Related]
18. Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic Sclerosis.
Gressenberger P; Jud P; Kovacs G; Kreuzer S; Brezinsek HP; Guetl K; Muster V; Kolesnik E; Schmidt A; Odler B; Adelsmayr G; Neumeister P; Brcic L; Zenz S; Weber K; Gary T; Brodmann M; Graninger WB; Moazedi-Fürst FC
J Pers Med; 2021 Jun; 11(7):. PubMed ID: 34201939
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.
Keret S; Henig I; Zuckerman T; Kaly L; Shouval A; Awisat A; Rosner I; Rozenbaum M; Boulman N; Dortort Lazar A; Molad Y; Sabbah F; Naffaa ME; Hardak E; Slobodin G; Rimar D
Rheumatology (Oxford); 2024 May; 63(6):1534-1538. PubMed ID: 37672021
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation improves cardiopulmonary exercise testing outcomes in systemic sclerosis patients.
Gadioli LP; Costa-Pereira K; Dias JBE; Moraes DA; Crescêncio JC; Schwartzmann PV; Gallo-Júnior L; Schmidt A; Oliveira MC
Rheumatology (Oxford); 2023 Feb; 62(SI):SI101-SI106. PubMed ID: 35861395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
